NovoCare Pharmacy (cash-pay) With the increasing demand for Wegovy and the inability of many patients to afford it, Novo Nordisk has introduced the NovoCare Pharmacy Solution
Mounjaro (priced at 14000-17500 per dose) has crossed Rs 100 crore in sales in India in just four months of launch, making it one of the countrys fastest-growing prescription brands ever by value
It is not a medicine or drug, is not FDA-approved, and is not intended for use in humans or animals
Lingvay said, the results reinforce the promise of semaglutide and other GLP-1RAs with benefits that appear to increase at a higher dose without compromising patient safety
In my years of medical practice, Ive never seen a class of medications gain as much attention in both medical and cultural spheres as GLP-1 agonists
Yes, that happens frequently